1. ResMed has achieved double-digit revenue and profit growth over the past 9 years due to continuous acquisitions and improved operational efficiencies; 2. The company's capital efficiency showed mixed results with improvements in gross profitability and asset turnover, but a longer cash conversion cycle; 3. The company is financially sound, and there is a margin of safety if another major acquisition is assumed next year.
Related Articles
- IonQ: Near-Term Revenue Analysis, Long Runway For Price Increase19 days ago
- Talkspace: Jumpstarting Momentum As Payor Programs Expand12 months ago
- Double Award Win for THU's CleanScreen Project: Using Light for Clean Touchscreens5 days ago
- October 2025 Perspective13 days ago
- CoreWeave's AI Climb Still Hides Untapped Firepower17 days ago
- Micron Technology, Inc. (MU) Q4 2025 Earnings Call Transcript21 days ago
- ASML Holding: $1.5B Mistral AI Misfireabout 1 month ago
- Home Testing: A Minimally Invasive Solution for Quick and Easy Determination of Blood Potassium Levelsabout 1 month ago
- Housing: 5 More Signs Of A Rapidly Deteriorating Marketabout 2 months ago
- Cenovus Energy's MEG Energy Acquisition: More Double-Digit Dividend Growth In The Future Likelyabout 2 months ago